Valuation: InterCure Ltd.

Market Cap 193M 0 168M 159M 144M 270M 18.52B 271M 1.9B 734M 9.41B 725M 709M 30.29B P/E 2024
-4.01x
P/E 2025 -4.87x
Enterprise Value 329M 0 287M 271M 246M 461M 31.6B 463M 3.25B 1.25B 16.07B 1.24B 1.21B 51.69B EV / Sales 2024
1.69x
EV / Sales 2025 1.16x
Free-Float
60.83%
Yield 2024 *
-
Yield 2025 -
1 day+0.43%
1 week+0.93%
Current month-9.20%
1 month+22.71%
3 months+20.76%
6 months+33.96%
Current year+0.68%
1 week 1,569
Extreme 1569
1,700
1 month 1,261.5
Extreme 1261.5
1,862
Current year 1,126.5
Extreme 1126.5
1,862
1 year 1,126.5
Extreme 1126.5
2,783.5
3 years 1,126.5
Extreme 1126.5
6,730
5 years 1,126.5
Extreme 1126.5
13,175
10 years 734.13
Extreme 734.1278
31,589.75
Manager TitleAgeSince
Chief Executive Officer 55 24/12/2019
Director of Finance/CFO 47 01/03/2020
General Counsel - 01/04/2022
Director TitleAgeSince
Director/Board Member 50 03/09/2015
Director/Board Member 66 14/12/2014
Chairman 55 13/02/2025
Date Insider Type Main position Quantity % Market Cap. Importance
18/3/26 Other

Chief Financial Officer

539,947 0.9874%
18/3/26 Other

Director

19,046 0.0348%
18/3/26 Other

Chief Executive Officer

17,285,455 31.6113%
Change 5-day change 1-year change 3-year change Capi.($)
+0.43%+0.93%-36.68%-49.46% 63.54M
0.00%-1.39%+7.98%+222.76% 347M
-3.36%0.00%-40.98%-32.08% 145M
+0.50%+0.50%+13.64%+100.00% 141M
-1.00%-2.94%-25.00%-58.05% 101M
Average -0.69%-0.58%-16.21%+36.64% 159.49M
Weighted average by Cap. -0.61%-0.81%-7.64%+97.61%

Financials

2024 2025
Net sales 239M 0 208M 197M 179M 335M 22.92B 336M 2.36B 909M 11.65B 897M 877M 37.49B 270M 0 236M 222M 202M 379M 25.93B 380M 2.66B 1.03B 13.18B 1.02B 992M 42.41B
Net income -67.8M -0 -59.12M -55.82M -50.69M -94.97M -6.51B -95.37M -669M -258M -3.31B -255M -249M -10.64B -35.71M -0 -31.14M -29.4M -26.7M -50.02M -3.43B -50.23M -352M -136M -1.74B -134M -131M -5.61B
Net Debt 133M 0 116M 109M 99.26M 186M 12.74B 187M 1.31B 505M 6.48B 499M 488M 20.84B 136M 0 119M 112M 102M 191M 13.08B 192M 1.34B 519M 6.65B 512M 501M 21.4B
Logo InterCure Ltd.
InterCure Ltd. is an Israel-based company engaged in the medical cannabis industry. Through its wholly owned subsidiary, Canndoc Ltd., the Company cultivates, produces, processes, markets, and distributes medical cannabis products. Its operations include the development and manufacture of pharmaceutical-grade medical cannabis products produced in accordance with Good Manufacturing Practice (GMP) standards. The Company offers a range of cannabis-based products for medical use and operates across various stages of the medical cannabis value chain, including cultivation, manufacturing, logistics, distribution, and retail activities. In addition, the Company is involved in the import, export, and commercialization of medical cannabis products and related healthcare solutions in Israel and selected international markets.
Employees
285
Date Price Change Volume
17/09/26 ILA 1,629.00 +0.43% 4,907
16/09/26 ILA 1,622.00 +2.21% 1,555
15/09/26 ILA 1,587.00 -2.22% 8,328
14/09/26 ILA 1,623.00 +0.56% 4,478
  1. Stock Market
  2. Stocks
  3. INCR Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!